The Latest

  • A person sits on a couch with a white patch on their upper arm and a rectangular device with a screen on their hip.
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    FDA warns Beta Bionics on unreported complaints, insulin pump changes

    The Food and Drug Administration warning letter detailed unreported low blood sugar and a software change to correct for delayed glucose readings.

  • A commercial building displays a “Boston Scientific” sign on its exterior. The structure features a smooth white facade with reflective windows and minimal architectural detailing, set against a partly cloudy sky.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Medtech M&A starts off strong in 2026

    Boston Scientific's planned $14.5 billion acquisition of Penumbra is the largest deal of the year so far.

  • A sign with company logo in red on a white background at the entrance to Johnson & JOhnson medical device unit
    Image attribution tooltip
    Mario Tama/Getty via Getty Images
    Image attribution tooltip

    Quantum Surgical buys J&J’s NeuWave

    Quantum, developer of the Epione robotic platform for cancer treatment, said the acquisition supports its strategy of reducing cancer mortality through robot-assisted tumor ablation.

  • A modern architectural design building featuring a red-brick façade with large glass windows displays a prominent sign of the Food and Drug Administration.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    FDA posts early alert for safety issue with Impella heart pump devices

    The cassettes have an increased risk of purge leaks that can lead to the loss of hemodynamic support.

  • A picture of the exterior of a Labcorp building.
    Image attribution tooltip
    Courtesy of Labcorp
    Image attribution tooltip

    Labcorp expands PathAI pact to roll out digital pathology platform in US

    Labcorp’s pathologists will use the software to review, interpret and manage digital images of slides for primary diagnosis.

    AI
  • Professional photo of Que Dallara
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic’s MiniMed prices IPO at up to $784M

    The diabetes spinoff plans to offer 28 million shares at $25 to $28 each.

  • Professional photo of Jake Leach
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    AdvaMed names Jake Leach as chair of diabetes sector

    The Dexcom CEO will lead the lobbying group’s sector representing diabetes tech companies around the world.

  • A picture of a man in a suit delivering a speech in front of a blue background.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip

    AdvaMed urges tailored tariff approach for medtech

    CEO Scott Whitaker said the medtech lobbying group stands ready to work with President Donald Trump to address trade imbalances by confronting unfair foreign practices in the sector.

  • European Commission President Ursula von der Leyen speaks in front of a blue background.
    Image attribution tooltip
    Johannes Simon via Getty Images
    Image attribution tooltip

    ‘A deal is a deal’: EU halts US pact over Trump’s new global tariff

    The bloc said it needed “full clarity” on the United States’ tariff plans after a Supreme Court ruling last week struck down many levies.

  • A lab technician runs Guardant Health's Shield blood test for colorectal cancer screening in a lab.
    Image attribution tooltip
    Courtesy of Business Wire
    Image attribution tooltip

    Guardant buys MetaSight for $59M upfront to acquire blood test tech

    MetaSight uses metabolomics, lipidomics and proteomics mass spectrometry technologies to develop tests for specific diseases, including conditions outside of oncology.

    M&A